EUPRAXIA PHARMACEUTICALS INC.
For the period ended Dec 31, 2024. Filed Mar 20, 2025.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2024 · Filed Mar 20, 2025
Use the contents to explore the available documents and sections.
EPRX$6.89+4.4%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · PROMOTERS
PROMOTERS
No person or company is, or has acted as, a promoter of the Company within the two most recently completed financial years or during the current financial year.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.